AI assistant
Sending…
IN8BIO, INC. — Director's Dealing 2024
Jun 14, 2024
35200_dirs_2024-06-14_c96ca78a-b4d9-476c-88df-88a59d91902c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2024-06-12
Reporting Person: FAIRBAIRN EMILY (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-06-12 | Stock Option (right to buy) | $1.47 | A | 33650 | Acquired | 2034-06-12 | Common Stock (33650) | Direct |
Footnotes
F1: One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 12, 2024; provided, however, that the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders, subject to
the Reporting Person continuing to provide service through each such date.
More from IN8BIO, INC.
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7